Community DVT Service. Phase 1: Patient visits their Registered GP/Out of Hours Provider
|
|
- Rosamund Stokes
- 5 years ago
- Views:
Transcription
1 Community DVT Service Quick Reference Guide Phase 1 and 2 Before referring a patient to the GP Care DVT Pathway please familiarise yourself with the Exclusion Criteria to help reduce the number of inappropriate referrals made to the Community DVT Service. Phase 1: Patient visits their Registered GP/Out of Hours Provider Where Patient presents with potential DVT: Registered GP/Out of Hours GP ( GP ) prepares Patient Record Card (electronic version available for auto completion of Patient details); GP performs Wells Score; Wells Criteria: Present Score Lower limb trauma or surgery or immobilisation in a plaster cast +1 Bedridden for more than three days or surgery within the last four weeks +1 Tenderness along line of femoral or popliteal veins +1 Entire limb swollen +1 Calf more than 3cm bigger circumference compared to other limb +1 Pitting oedema +1 Dilated collateral superficial veins (non-varicose) +1 Malignancy (including treatment up to six months previously) +1 Previous DVT +1 Alternative diagnosis more likely than DVT -2 Clinical probability of DVT with score >2 High 1-2 Moderate <1 Low GP performs D-dimer test using Near Patient Testing Kit where: Wells Score < 1 but high clinical suspicion; or Wells Score >/= 1. Select appropriate instruction dependent upon preferred D-Dimer Testing Kit used; CLEARTEST D-dimer test: Tear open foil pouch and place the test device on a clean and level surface. Note: o Best results will be obtained if the test is performed immediately after opening the foil pouch Take finger prick blood sample: o Wash the patient s hand with soap and warm water or clean with an alcohol swab. Allow to dry. o Massage the hand without touching the puncture site by rubbing down the hand towards the fingertip of the middle or ring finger. o Puncture the skin with a sterile lancet. Wipe away the first sign of blood. o Gently rub the hand from wrist to palm to finger to form a rounded drop of blood over the puncture site. o Note venous sample can be taken as alternative if necessary Using the pipette supplied, hold the pipette horizontally and draw up sufficient blood for the test. Allow 2 hanging drops of fingerstick whole blood specimen (approximately 40 µl) to fall into the centre of the specimen well of the test device. Immediately add 1 drop of buffer solution to the specimen well and start the timer. Leave the test device lying horizontal and wait for the coloured line(s) to appear. Read results at 10 minutes (although positive results can often be seen much earlier than this) Do not interpret results after more than 15 minutes. Author : NC/PN Page 1 of 5 June 2012
2 CLEARVIEW D-dimer test: Tear open foil pouch and place the test device on a flat horizontal surface. Note: o Once pouch is opened, commence use of the device within 10 minutes o Test and PC (Patient Control) zones are dyed yellow for manufacturing quality control purposes; the dye does not interfere with the test results Take finger prick blood sample: o Lance patient s finger using sterile lancing device (min depth 1.8mm) o Using the capillary pipette provided collect finger prick blood sample (Do not use the venous pipettes.) Hold a capillary pipette horizontally and touch the tip to the blood drop on the patient s finger Do not squeeze the bulb of the pipette during sampling or obstruct the vent; capillary action will automatically draw the blood into the pipette Allow the pipette to fill to the black line o Note venous sample can be taken as alternative if necessary Immediately dispense all of the blood (35ul) from the capillary pipette into the round sample well of the test device o Hold the capillary pipette in a vertical position above the round sample well o Place a finger over the vent hole in the capillary pipette and dispense all of the blood into the well Allow the blood sample to completely penetrate the sample pad before adding 2 drops of the buffer solution Leave the test device lying horizontal and read the result at 10 minutes (although positive results can often be seen much earlier than this) Further instruction including diagrams is available at If D-dimer is negative, and ultrasound is not required, then GP completes sections 1a and 2a of Patient Record Card and faxes to GP Care on The clinical diagnosis should not be based on the result of the D-dimer test alone. The full clinical context of the patient must be included when making a diagnostic decision taking into account the clinical signs and other relevant information such as the Wells pre-test probability score or equivalent. Therefore the D-dimer must not be used as a stand alone test. If D-dimer is positive, or the GP has a high clinical suspicion of the presence of DVT, then GP: o Explains implications of DVT to Patient and that it is only a potential DVT at this stage; o Calculates appropriate Clexane dosage (1.5mg per 1kg of body weight) and administers to Patient (see table on following page). Author : NC/PN Page 2 of 5 June 2012
3 (Treatment of DVT by subcutaneous injection of Clexane, 1.5mg/kg (150units/kg) every 24 hours for at least 5 days (or until excluded or adequate oral anticoagulation established)) CLEXANE DOSES Weight (kg) Dose (mg) Size of vial Vol (ml) unit/ml 100 units or under dose required volume/ After 100 units ie 67kgs weight = volume/ CLEXANE DOSES Weight (kg) Dose (mg) Size of vial Vol (ml) unit/ml After 150 units ie 103kgs weight = volume/ x x x x x x x x x x The GP then: o Books a same or next working day Ultrasound Appointment by calling GP Care on (office hours) and informs the Patient of Ultrasound Appointment time and location; NB: If the Patient Appointment is after hours and there is no answer at GP Care then the GP advises the patient that GP Care will telephone the patient as soon as possible on the next working day and ensures the telephone number that the patient will be contactable on is written on the Patient Record Card; o Completes sections 1a, 1b, 2a, 2b and 3 of Patient Record Card, immediately faxes to GP Care on and gives original to Patient to take to the Ultrasound Appointment. NB: If Patient has to wait over a weekend for an Ultrasound Appointment then the GP refers the Patient to attend Frendoc on each day over the weekend to receive further Clexane injections pending the Ultrasound Scan. The referral should be made by faxing the Patient Record Card to Frendoc on ; a copy is also faxed to GP Care. The patient should be advised to telephone Frendoc after 08.00am on Saturday to arrange a same day appointment on (the telephone number is printed on the Frendoc map). Author : NC/PN Page 3 of 5 June 2012
4 Phase 2: Ultrasound Scan The Patient attends the GP Care Ultrasound Clinic at Christchurch (Downend), West Walk (Yate), Almondsbury Surgery or Greenway Community Practice (Southmead), staffed by GP Care s team of ultrasonographers. If Ultrasound Scan is negative Patient is discharged back to the Registered GP by the relevant GP Care Ultrasound Clinic; and the GP is notified of the scan result by fax; If Ultrasound Scan is positive: o Patient is immediately transferred to the Duty Doctor at the Treatment Centre where they have been scanned; o Registered GP is notified of positive Scan result by fax. NB: Following day 1 of anticoagulation, patients can attend an alternative DVT Treatment Centre if they wish but have to attend that centre for the remainder of the anticoagulation course. As well as the four Treatment Centres listed above, patients can also choose to be treated at Seymour Medical Centre in Easton, from Day 2 onwards. Phase 3: Anticoagulation at DVT Treatment Centres Refer to separate Guide to Anticoagulation Pulmonary Embolism If at any point during the pathway a Pulmonary Embolism is suspected, the Duty Doctor should contact the patient s registered GP and ascertain consent to refer the patient directly to secondary care. The clinicians at secondary care will assess whether the patient is suitable for community anticoagulation; if this is deemed the case GP Care will accept the patient back onto the pathway at the centre of patient s choice. DNAs Procedures to minimise risk of DNAs are as follows: If at any point a Patient does not attend an anticoagulation appointment then the DVT Treatment Centre should endeavour to make contact with the Patient by phone; If no contact has been possible within 24 hours of the appointment time the DVT Treatment Centre should send a Chasing Patient Letter using the pro forma letter in the Blue DVT File and notify GP Care and inform the Patient s Registered GP that the Patient is being discharged back to the Registered GP; Responsibility for the Patient then reverts to the Patient s Registered GP. House-bound Patients requiring transport The Service is available only to Patients who can attend a DVT treatment centre for an Ultrasound Scan and follow-up anticoagulation. Patients not able to use Warfarin The Service is available only to Patients who can use Warfarin. Payments by GP Care to Performers GP Care will pay Performers according to the work performed as documented on the Patient Record Card. Consumables (D-dimer tests, Clexane and Coaguchek testing strips will also be reimbursed by GP Care on a usage basis); Payments will be made on a calendar month basis in respect of work performed for Patients whose Pathways were completed in that calendar month; An electronic pro-forma invoice detailing services provided and amounts due to the Performer will be supplied by GP Care at the end of each month. Once agreed, the Performer should print the invoice on their headed notepaper and forward it to GP Care for payment. NB: It is critical that Patient Record Cards (including those for Negative D-dimer tests) are completed on an accurate and timely basis and forwarded to GP Care in order that Performers are remunerated correctly. Author : NC/PN Page 4 of 5 June 2012
5 Inclusion Criteria Aged 18 years and over Prior to Doppler Ultrasound: Patients assessed to be at significant risk of DVT based on a clinical assessment and examination by a qualified medical practitioner together with Wells scoring and a D-dimer test if appropriate. Following a positive Doppler Ultrasound scan: Patients who have a deep vein thrombosis proven on scan and who require treatment to prevent complication of the thrombosis. Exclusion Criteria Age less than 18 years Housebound patients Visiting patients (i.e. Non South Gloucestershire PCT patients) Absolute Contra indications: (Please seek guidance from a consultant physician prior to referring patients with any of the following conditions to the Community DVT Service) Pulmonary Embolism or suggestion thereof (including dyspnoea or chest pain+ unilateral leg swelling) Potential bleeding lesions Active Peptic Ulcer, oesophageal varices, aneurysm and proliferative retinopathy Recent Organ biopsy Recent Trauma or Surgery to the head, orbit or spine Recent stroke or transient ischaemic attack Confirmed intracranial or intraspinal bleed or following surgery to the eye or central nervous system (within 1 month) Infective Endocarditis History of heparin induced thrombocytopenia or thrombosis Homozygous protein C deficiency (risk of skin necrosis) Other disease process that requires admission Axillary Vein DVT Positive DVT but contraindication to anticoagulation Patients with complications that prevent use of Warfarin Pregnant women and breast feeding mothers Hypersensitivity to enoxaparin sodium, Heparin or its derivatives including other low molecular weight heparins. Relative Contraindications Past history of gastrointestinal bleeding Liver disease/liver damage Renal failure Alcoholism Mental Impairment Thrombocytopenia Coagulation disorders Interacting Drugs, in particular non steroidal anti-inflammatory drugs, Clopidogrel and glucocorticoids Poor attendance for regular blood tests or commitment to treatment. Uncontrolled hypertension Recent surgery (within 1 month) other than for minor conditions Social circumstances which may prevent community based treatment Pain inadequately controlled Mentally unstable or uncooperative patient. Proliferative diabetic retinopathy. Should a patient exhibit any of the above exclusions, at any stage during the Service Pathway, the Treatment Centre Duty Doctor should liaise with the patient s registered GP to agree the most suitable means of treatment. Author : NC/PN Page 5 of 5 June 2012
Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range
Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page
More informationPatient Information. Preventing and treating blood clots
Patient Information Preventing and treating blood clots 1_Clexane_Patient_Booklet_AW05.indd 1 8/04/2016 11:26 a The information provided in this document is for patients prescribed CLEXANE, and should
More informationSuspected Deep Vein Thrombosis (DVT) Assessment
CHI no... First name... DOB... /... /... Last name... Sex: c M c F Address...... Telephone... or attach addressograph label here Hospital/Location: c Hairmyres c Monklands c Wishaw Other (specify)... Ward/Base...
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationCoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood
CoaguChek S System This is a CLIA-waived System Quick Reference Guide Coagulation Testing with Fresh Whole Blood May not print or view at 100% All unmarked prints black. Coag Swoosh prints gradients of
More informationONE-STEP WHOLE BLOOD H.PYLORI TEST. Product Code: 24529
ONE-STEP WHOLE BLOOD H.PYLORI TEST Product Code: 24529 Contents of Package: - Foil Package (Contains: Test Device and Dropper) - Vial of Test Solution - Finger Stick Device Alcohol Swab Materials required
More informationShared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines
More informationDETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE
DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE PRINCIPLE: The Determine HIV-1/2 Ag/Ag Combo assay is a qualitative immunoassay for the simultaneous detection of Human Immunodeficiency
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationThe role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes
The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes You have been fitted with a Guardian Connect continuous
More informationUnigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS
Unigold Recombigen HIV 1/2 Training for HIV Testing Sites Updated: February 2018 Cicely Richard Office of HIV/AIDS Updated: February 2018 Cicely Richard Office of HIV/AIDS UNIGOLD RECOMBIGEN HIV 1/2 TRAINING
More informationCLINICAL GUIDELINES ID TAG
Title: Author: Speciality/ Division: Directorate: Date Uploaded: Review Date: September 2019 CG ID TAG CG0423 CLINICAL GUIDELINES ID TAG Clinical Guideline for Alteplase in intra-arterial thrombolysis
More informationVenous Thromboembolism (VTE)
Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/
More informationDeep Vein Thrombosis
Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,
More informationStep-by-Step Instructions For OraQuick HCV Rapid Antibody Test
Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Complexity: WAIVED for fingerstick whole blood and venipuncture whole blood. A Certificate of CLIA Waiver is required to perform the test
More informationThe Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)
Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or
More informationGood to know. Tips and tricks for accurate blood glucose monitoring
Good to know Tips and tricks for accurate blood glucose monitoring Tip 1 Washing your hands No place for dirt Accurate blood glucose readings are essential for your diabetes care. Correct self-testing
More informationPreventing Blood Clots in Adult Patients
Manchester Royal Eye Hospital Surgical Services Information for Patients Preventing Blood Clots in Adult Patients This leaflet will give you information on how to reduce the risk of developing blood clots
More informationSkills workshop: Screening tests for syphilis
1D Skills workshop: Screening tests for syphilis Objectives When you have completed this skills workshop you should be able to: Screen a patient for syphilis with the syphilis rapid test and the RPR card
More informationPathology Service User Guide Haematology
Pathology Service User Guide Haematology St Richard s This section of the Pathology Service User Guide includes: Anticoagulant Therapy Information about the Anticoagulant Clinic Low Molecular Weight Heparin
More informationTreatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin
Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin You have been given this leaflet because you have a blood clot. Normally blood flows freely around the body without
More informationGuidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting
ANTICOAGULANT SERVICE Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting Introduction Fast loading of warfarin carries a risk of over anticoagulation
More informationTo provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.
Module 9 Performing HIV Rapid Tests Purpose To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status. Pre-requisite Modules Module 3: Overview
More informationPE Pathway. The charts are listed as follows:
PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using
More informationDr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust
MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital
More informationPoint of Care Testing for INR using CoaguChek XS Plus
Point of Care Testing, Pathology Page 1 of 18 Point of Care Testing for INR using CoaguChek XS Plus EDITION No 1.4 DATE OF ISSUE Feb 2014 REVIEW INTERVAL AUTHOR LOCATION OF COPIES 3 YEARS D O Neill 1.
More informationNICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1
The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS
More informationCHAPTER 2 VENOUS THROMBOEMBOLISM
CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology
More informationLocal steroid injections to joints and soft tissues
Local steroid injections to joints and soft tissues Pain Management Team Patient Information Leaflet Introduction This leaflet will provide you with information about what to expect when you come in for
More informationST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set
Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not
More informationReducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge
Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein
More informationDVT Primary Care Prescribing Pathway
DVT Primary Care Prescribing Pathway Scope Classification Author Health Economy Wide Guideline East Lancashire Medicines Management Board (Reviewed December 207) Authorised by ELMMB Date February 208 Reviewed
More informationItems in the package:
Intended Use: The EasyLife Hb Monitoring System is designed for in vitro diagnostic use only (external use only), and is suitable for self-testing. The system is for healthcare professionals and persons
More informationSpecimen Collection Policies
Specimen Collection Policies Purpose Great River Medical Center Laboratory is a hospital-based and outreach laboratory with specific standards of excellence. To best serve our patients, all specimens will
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationMDT2. Self-Monitoring Blood Glucose System. Quick Reference Guide
MDT2 Self-Monitoring Blood Glucose System Quick Reference Guide Inserting Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow. 2. Insert two batteries.
More information1.0 PATIENT CARE Including Physical Healthcare
SECTION: 1.0 PATIENT CARE Including Physical Healthcare POLICY /PROCEDURE: 1.33 NATURE AND SCOPE: SUBJECT: PROCEDURE - TRUST WIDE VENOUS THROMBOEMBOLISM (VTE) This procedure details Venous Thromboembolism
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationUSO PROFESSIONALE PROFESSIONAL USE
Gima S.p.A. - Via Marconi, 1-20060 Gessate (MI) Italy Italia: tel. 199 400 401 - fax 199 400 403 Export: tel. +39 02 953854209/221/225 fax +39 02 95380056 gima@gimaitaly.com - export@gimaitaly.com www.gimaitaly.com
More informationThrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers
Thrombosis and Anticoagulation Team Warfarin Information for patients, relatives and carers What is warfarin? Warfarin is an anticoagulant. Anticoagulants are drugs which prevent harmful blood clots forming
More informationEME. Self-Monitoring Blood Glucose System. Quick Reference Guide
EME Self-Monitoring Blood Glucose System Quick Reference Guide Inserting Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow and pulling the door
More informationQUICK REFERENCE INSTRUCTIONS. THYROCHEK TSH Cassette
QUICK REFERENCE INSTRUCTIONS THYROCHEK TSH Cassette A certificate of CLIA waiver is required to perform the testing in a waived setting. If the laboratory does not have a Certificate of Waiver, the Application
More informationStandard Operating Procedure for. the Safe Administration of Dalteparin (Fragmin), Tinzaparin (Innohep) and Enoxaparin (Clexane) in the Community
Standard Operating Procedure for the Safe Administration of Dalteparin (Fragmin), Tinzaparin (Innohep) and Enoxaparin (Clexane) in the Community DOCUMENT CONTROL: Version: 2. Ratified by: Quality Assurance
More informationINTRODUCTION Indication and Licensing
City and Hackney Clinical Commissioning Group Homerton University Hospital Foundation Trust DRUG NAME: Apixaban (Eliquis ) Transfer of Care document Indication: Treatment of acute venous thromboembolism
More informationDear HighQ Check System Owner :
Dear HighQ Check System Owner : Thank you for purchasing the HighQ Check Blood Glucose Monitoring System. This manual provides important information to help you to use the system properly. Before using
More informationRADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS
RADIOFREQUENCY ABLATION This minimally invasive treatment involves closing the faulty veins using a keyhole approach thereby avoiding the larger cuts and avoiding stripping of the veins. Professor M Baguneid
More informationAlere INRatio 2 METHOD AND SAMPLE COLLECTION
Alere INRatio 2 METHOD AND SAMPLE COLLECTION 1. PURPOSE AND SCOPE The purpose of this document is to describe the procedure for performing an INR test using the Alere INRatio2 analyser. The INRatio2 meter
More informationNorth East Essex Medicines Management Committee
Colchester Hospital University NHS Foundation Trust North East Essex Clinical Commissioning Group North East Essex Medicines Management Committee ORAL ANTICOAGULANT (Vit K antagonist only) MANAGEMENT GUIDELINES
More informationAppendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES. CP Direct Vision Sclerotherapy Clinical procedure
Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES CP Direct Vision Sclerotherapy Clinical procedure 1 PURPOSE This procedure summarises the actions required
More informationI can show you how to check my child s blood sugar
Our Journey with Diabetes Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. I can show you how to check my child s blood sugar Testing Blood Sugar Blood sugar levels
More informationBLOOD COLLECTION GUIDELINES
I. Patient Identification Lee Memorial Health System Lee County, FL CLINICAL LABORATORY BLOOD COLLECTION GUIDELINES A. Inpatient / Outpatient with armband 1. When possible, ask patient to state their name
More informationP-RMS: LT/H/PSUR/0004/001
Core Safety Profile Active substance: Dalteparine Pharmaceutical form(s)/strength: Solution for injection, 2500 I.U./0.2ml, 2500 I.U./ml, 5000 I.U./0.2ml, 7500 I.U./0.3ml, 7500 I.U./0.75ml, 10000 I.U./0.4ml,
More informationVenous Thromboembolism (VTE) A guide for patients with cancer
Cancer Patient InformationPtient Education Inform Venous Thromboembolism (VTE) A guide for patients with cancer Table of Contents Venous Thromboembolism (VTE)... 3 Deep Vein Thrombosis (DVT) and Pulmonary
More informationI know my value CoaguChek XS Pro system
I know my value CoaguChek XS Pro system The smart way to manage your anticoagulation clinic CoaguChek XS Pro system A barcode scanner can make a difference There has been an extraordinary increase in the
More informationEdoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF
Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Traffic light classification- Amber 2 specialist initiation / recommendation Information
More informationCatalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line)
For in vitro diagnostic use. CLIA Complexity for Whole Blood: WAIVED INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies
More informationCatalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents
For in vitro diagnostic use. CLIA Complexity: MODERATE INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to
More informationCollection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA PCR. MOH Regional Trainings March 2013
Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA MOH Regional Trainings March 2013 Outline Introduce DBS testing Rationale Testing algorithm Sample collection, storage and transportation
More informationCLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation
CLIA Complexity for Whole Blood: WAIVED Intended Use The is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to Helicobacter pylori in whole blood. The
More informationPulmonary Embolism Pathway
Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label Pulmonary Embolism Pathway Clinical History Comments Hospital
More informationHow to prevent blood clots whilst in hospital and after your return home
How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationRivaroxaban film coated tablets are available in 2 strengths for this indication: 15mg and 20mg.
Primary Care Prescriber Information RIVAROXABAN (XARELTO ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism INDICATION Rivaroxaban is a non-vitamin K antagonist
More informationWhat is Clexane and what is it used for?
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION What is Clexane and what is it used for? An information guide What is Clexane and what is it used for? CLEXANE (also known as Enoxaparin)
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationVenous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital
Please Note: This policy is currently under review and is still fit for purpose. Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital This procedural document supersedes
More informationANTIBODY SCREENING by Uni-Gold Recombigen HIV
ANTI-HIV SPECIMEN 1 REQUIREMENTS ANTIBODY SCREENING by Uni-Gold Recombigen HIV PRINCIPLE: The Uni-Gold Recombigen HIV was designed as a rapid immunoassay and is intended to detect antibodies to HIV- 1
More informationSurgery for Patients on Oral Anticoagulants
Surgery for Patients on Oral Anticoagulants (for example: warfarin, rivaroxaban, apixaban, dabigatran, edoxaban) Surgery Patient Information Leaflet You have been given this leaflet because you are due
More informationInhixa (Enoxaparin Sodium)
Inhixa (Enoxaparin Sodium) P R E V ENTIS SAFETY D E V I C E P R E V E N T I S I S A N AU TO M AT I C N E E D L E S H I E L D I N G S Y S T E M, W H I C H H A S A C O V E R T H AT E X T E N D S O V E R
More informationDr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationManagement of Central Venous Access Devices. Blood Glucose Monitoring
Management of Central Venous Access Devices Blood Glucose Monitoring Purpose To provide education on the standard of care regarding the use and monitoring of the Accu- Chek Blood glucose machine, including
More informationPrimary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism
Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism INDICATION Edoxaban is a non-vitamin K antagonist oral
More informationInferior Vena Cava Filter for DVT
Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If
More informationRivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy
Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about
More informationFOR INFORMATIONAL USE ONLY
CLIA-WAIVED PROCEDURE FOR WHOLE BLOOD INTENDED USE QuickVue+ Infectious Mononucleosis test is a rapid Color lmmunochromatographic Assay (CICA) for the detection of Infectious Mononucleosis lgm heterophile
More informationGOING IN THE INJECTING THE
GOING IN THE INJECTING THE GROIN FEMORAL VEIN The vein in your groin is not like the veins in your arms. People who inject in the groin suffer more serious health problems and some of them die. Why Inject
More informationAccu-Chek Inform II: Point of Care Glucose Testing. Sharp Healthcare 2014
Accu-Chek Inform II: Point of Care Glucose Testing Sharp Healthcare 2014 OBJECTIVES At the completion of this module the participant will be able to: Learn the proper technique of performing a finger stick
More informationTitle Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines
Document Control Title Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines Author Team Directorate Medical Date Version Status Issued
More informationPeripheral Vascular Examination. Dr. Gary Mumaugh Western Physical Assessment
Peripheral Vascular Examination Dr. Gary Mumaugh Western Physical Assessment Competencies 1. Inspection of upper extremity for: size symmetry swelling venous pattern color Texture nail beds Competencies
More informationDiagnosis of Venous Thromboembolism
Diagnosis of Venous Thromboembolism An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric Tseng MD MScCH, University of
More informationDRUG NAME: EDOXABAN (LIXIANA ) Transfer of Care document Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism
City and Hackney Clinical Commissioning Group Homerton University Hospital Foundation Trust DRUG NAME: EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism
More informationA A U
PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency
More informationCoaguChek Outpatient Clinic: CoaguChek XS - Quick Reference Guide
CoaguChek Outpatient Clinic: CoaguChek XS - Quick Reference Guide CoaguChek XS Quick Reference Guide Page 1 Page 1 of 18 Coaguchek XS Monitor A DISPLAY B - M (memory button) o To recall results from memory
More information2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate
Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 249: Atrial fibrillation - Dabigatran Etexilate 1 Name of Commissioning Team Long Term Conditions Commissioning Team
More informationpat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16
pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationHand & Plastics Physiotherapy Department Extensor Tendon Repair Zone IV and above Information for patients
Oxford University Hospitals NHS Trust Hand & Plastics Physiotherapy Department Extensor Tendon Repair Zone IV and above Information for patients Introduction You have had surgery to repair one or more
More informationThe Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT
n The Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT Information for patients Catheter directed thrombolysis and pelvic venous stenting
More informationBlood Glucose Monitoring System
Blood Glucose Monitoring System Self monitoring of blood glucose (SMBG) is an important part of diabetes care, but the high cost of testing can make it difficult. At ACON, our goal is to provide high quality
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationEasyMax Voice III Self-Monitoring Blood Glucose System. Quick Reference Guide
EasyMax Voice III Self-Monitoring Blood Glucose System Quick Reference Guide 1 Installing Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow and
More informationDeep Vein Thrombosis
Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.
More informationDeep Vein Thrombosis and Pulmonary Embolism
Page 1 of 12 PATIENT EDUCATION Deep Vein Thrombosis and Pulmonary Embolism Take Steps to Prevent DVTs and PEs Deep vein thrombosis and pulmonary embolism are serious conditions that can affect people of
More informationDeep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients
Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients What is a deep vein thrombosis (DVT)? A DVT is a blood clot that forms within a vein deep in the leg but can
More informationHIV Testing in Children
Module 6 HIV Testing in Children Total Module Time: 185 minutes (3 hours, 5 minutes) Learning Objectives After completing this module, participants will be able to: Understand the procedure for collecting
More informationThis information is intended as a general guide only. Please ask if you have any questions relating to this information.
Foam Sclerotherapy (Varicose vein injections) Vascular Surgery This information is intended as a general guide only. Please ask if you have any questions relating to this information. Varicose Veins Veins
More informationTips for Training New Customers
Tips for Training New Customers Good Habits: Test Strips Recap vial immediately and tightly after removing a single test strip. Never remove the desiccant from the vial. Do not lay test strips out ahead
More informationUltrasound guided neck lump biopsy
Ultrasound guided neck lump biopsy Information for patients Diagnostic Imaging Department X-Ray and Scanning Specialist Support If you require this leaflet in another language, large print or another format,
More informationVenous Thromboembolic Events (VTEs)
Venous Thromboembolic Events (VTEs) This Infosheet explains what a VTE is, what the causes and risk factors for VTEs are, the symptoms of a VTE, how they can be treated and some tips for self-management.
More information